nasdaq
Dec 19
103
30K
6.41%
“How do we take the current approved therapies and combine them with the next set of breakthroughs?”
Dir. Of Scientific Programs at James P. Allison Institute @MDAndersonCancerCenter, Dr. Pam Sharma, discusses immuno-oncology innovations with Breakthrough Economy host @JenRogersHere.
nasdaq
Dec 19
103
30K
6.41%
Cost:
Manual Stats:
Include in groups:
Products:
